Insights into Parkinson's disease models and neurotoxicity using non-invasive imaging

Toxicology and Applied Pharmacology

Volumn 207, Issue 2 SUPPL., 2005, Pages 251-256

  Sánchez Pernaute, Rosario ^a,b   Brownell, Anna Liisa ^a,c   Jenkins, Bruce G ^c   Isacson, Ole ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b MCLEAN HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Dopamine; Imaging; Neurotoxicity; Parkinson disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIINFLAMMATORY AGENT; CARBON 11; CYCLOOXYGENASE 2 INHIBITOR; DOPAMINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROTRANSMITTER; OXIDOPAMINE; PESTICIDE;

CELL ACTIVATION; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISEASE COURSE; DOPAMINERGIC SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IN VIVO STUDY; INFLAMMATION; ISOTOPE LABELING; MICROGLIA; NERVE CELL LESION; NEUROIMAGING; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY;

EID: 24644471138     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.02.039     Document Type: Conference Paper

References (53)

1. R.B. Banati Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain Br. Med. Bull. 65 2003 121 131
2. R.B. Banati, R. Myers, and G.W. Kreutzberg PK ('peripheral benzodiazepine')-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia J. Neurocytol. 26 1997 77 82
3. R.B. Banati, G.W. Goerres, R. Myers, R.N. Gunn, F.E. Turkheimer, G.W. Kreutzberg, D.J. Brooks, T. Jones, and J.S. Duncan [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis Neurology 53 1999 2199 2203
4. K.S. Bankiewicz, R. Sanchez-Pernaute, Y. Oiwa, M. Kohutnicka, A. Cummins, and J. Eberling Preclinical models of Parkinson's disease Curr. Protoc. Neurosci. 1999 9.4.1 9.4.32 (Suppl. 9)
5. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
6. R. Betarbet, T.B. Sherer, and J.T. Greenamyre Animal models of Parkinson's disease Bioassays 24 2002 308 318
7. L.M. Bjorklund, R. Sanchez-Pernaute, S. Chung, T. Andersson, I.Y. Chen, K.S. McNaught, A.L. Brownell, B.G. Jenkins, C. Wahlestedt, K.S. Kim, and O. Isacson Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model Proc. Natl. Acad. Sci. U.S.A. 99 2002 2344 2349
8. V. Bonifati, P. Rizzu, F. Squitieri, E. Krieger, N. Vanacore, J.C. van Swieten, A. Brice, C.M. van Duijn, B. Oostra, G. Meco, and P. Heutink DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism Neurol. Sci. 24 2003 159 160
9. V. Bonifati, B.A. Oostra, and P. Heutink Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease J. Mol. Med. 82 2004 163 174
10. A.-L. Brownell, B.G. Jenkins, D.R. Elmaleh, T.W. Deacon, R.D. Spealman, and O. Isacson Combined PET/MRS studies of the brain reveal dynamic and long-term physiological changes in a Parkinson's disease primate model Nat. Med. 4 1998 1308 1312
11. A.L. Brownell, E. Livni, W. Galpern, and O. Isacson In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants Ann. Neurol. 43 1998 387 390
12. A.-L. Brownell, B.G. Jenkins, and O. Isacson Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease Biomed. Pharmacother. 53 1999 131 140
13. A.L. Brownell, K. Canales, Y.I. Chen, B.G. Jenkins, C. Owen, E. Livni, M. Yu, F. Cicchetti, R. Sanchez-Pernaute, and O. Isacson Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model Neuroimage 20 2003 1064 1075
14. A. Cagnin, R. Myers, R.N. Gunn, A.D. Lawrence, T. Stevens, G.W. Kreutzberg, T. Jones, and R.B. Banati In vivo visualization of activated glia by [11C](R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion Brain 124 2001 2014 2027
15. A. Cagnin, A. Gerhard, and R.B. Banati The concept of in vivo imaging of neuroinflammation with [11C](R)-PK11195 PET Ernst Schering Res. Found. Workshop 2002 179 191
16. R. Camsonne, C. Crouzel, D. Comar, M. Maziere, C. Prenant, J. Sastre, M.A. Moulin, and A. Syrota Synthesis of N-(11-C) methyl, N-methyl-1 propyl), (chloro-2 phenyl)-1 isoquinoleine carboxamide-3 (PK 11195): a new ligand for peripheral benzodiazepine receptors Label. Comp. Radiopharm. 21 1984 985 991
17. Y.C.I. Chen, W.R. Galpern, A.-L. Brownell, R.T. Matthews, M. Bogdanov, O. Isacson, J.R. Keltner, M.F. Beal, B.R. Rosen, and B.G. Jenkins Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis and behavioral data Magn. Reson. Med. 38 1997 389 398
18. Q. Chen, A.H. Andersen, Z. Zhang, A. Ovadia, W.A. Cass, D.M. Gash, and M.J. Avison Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys Exp. Neurol. 158 1999 63 75
19. Y.I. Chen, A.L. Brownell, W. Galpern, O. Isacson, M. Bogdanov, M.F. Beal, E. Livni, B.R. Rosen, and B.G. Jenkins Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment NeuroReport 10 1999 2881 2886
20. Y.C. Chen, J.B. Mandeville, T.V. Nguyen, A. Talele, F. Cavagna, and B.G. Jenkins Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents J. Magn. Reson. Imaging 14 2001 517 524
21. F. Cicchetti, A.L. Brownell, K. Williams, Y.I. Chen, E. Livni, and O. Isacson Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging Eur. J. Neurosci. 15 2002 991 998
22. M.T. Corasaniti, M.C. Strongoli, D. Rotiroti, G. Bagetta, and G. Nistico Paraquat: a useful tool for the in vivo study of mechanisms of neuronal cell death Pharmacol. Toxicol. 83 1998 1 7
23. G.C. Davis, A.C. Williams, S.P. Markey, M.H. Ebert, E.D. Caine, C.M. Reichert, and I.J. Kopin Chronic Parkinsonism secondary to intravenous injection of meperidine analogues Psychiatry Res. 1 1979 249 254
24. L.S. Forno, J.W. Langston, L.E. DeLanney, and I. Irwin An electron microscopic study of MPTP-induced inclusion bodies in an old monkey Brain Res. 448 1988 150 157
25. J.T. Greenamyre, and T.G. Hastings Biomedicine. Parkinson's-divergent causes, convergent mechanisms Science 304 2004 1120 1122
26. P. Hantraye, A.-L. Brownell, D. Elmaleh, R.D. Spealman, U. Wullner, G.L. Brownell, and O. Isacson Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism NeuroReport 3 1992 265 268
27. D.J. Heeger, and D. Ress What does fMRI tell us about neuronal activity? Nat. Rev. Neurosci. 3 2002 142 151
28. E.C. Hirsch, S. Hunot, P. Damier, and B. Faucheux Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol. 44 3 Suppl. 1 1998 S115 S120
29. G.D. Honey, T. Sharma, J. Suckling, V. Giampietro, W. Soni, S.C. Williams, and E.T. Bullmore The functional neuroanatomy of schizophrenic subsyndromes Psychol. Med. 33 2003 1007 1018
30. O. Hornykiewicz, C. Pifl, G. Schingnitz, and S.J. Kish The cause of Parkinson's disease: MPTP, aging and the striatal dopamine loss G. Nappi Neurodegenerative Disorders: The Role Played By Endotoxins and Xenobiotics 1988 Raven Press New York 73 87
31. B.G. Jenkins, R. Sanchez-Pernaute, A.L. Brownell, Y.C. Chen, and O. Isacson Mapping dopamine function in primates using pharmacologic magnetic resonance imaging J. Neurosci. 24 2004 9553 9560
32. T. Kunz, and E.H. Oliw The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus Eur. J. Neurosci. 13 2001 569 575
33. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
34. J.W. Langston, L.S. Forno, C.S. Rebert, and I. Irwin Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in the squirrel monkey Brain Res. 292 1984 390 394
35. M. Laruelle, A. Abi-Dargham, C.H. van Dyck, W. Rosenblatt, Y. Zea-Ponce, S.S. Zoghbi, R.M. Baldwin, D.S. Charney, P.B. Hoffer, and H.F. Kung SPECT imaging of striatal dopamine release after amphetamine challenge J. Nucl. Med. 36 1995 1182 1190
36. J.B. Mandeville, J.J. Marota, B.E. Kosofsky, J.R. Keltner, R. Weissleder, B.R. Rosen, and R.M. Weisskoff Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation Magn. Reson. Med. 39 1998 615 624
37. C.D. Marsden Parkinson disease Postgrad. Med. J. 68 1992 538 543
38. E.G. McGeer, and P.L. McGeer The importance of inflammatory mechanisms in Alzheimer disease Exp. Gerontol. 33 1998 371 378
39. P.L. McGeer, C. Schwab, A. Parent, and D. Doudet Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine administration Ann. Neurol. 54 2003 599 604
40. L. Minghetti, and G. Levi Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide Prog. Neurobiol. 54 1998 99 125
41. M. Nakayama, K. Uchimura, R.L. Zhu, T. Nagayama, M.E. Rose, R.A. Stetler, P.C. Isakson, J. Chen, and S.H. Graham Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia Proc. Natl. Acad. Sci. U.S.A. 95 1998 10954 10959
42. S. Nogawa, F. Zhang, M.E. Ross, and C. Iadecola Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage J. Neurosci. 17 1997 2746 2755
43. S. Ogawa, T.M. Lee, A.R. Kay, and D.W. Tank Brain magnetic resonance imaging with contrast dependent on blood oxygenation Proc. Natl. Acad. Sci. U.S.A. 87 1990 9868 9872
44. Y. Oiwa, R. Sanchez-Pernaute, J. Harvey-White, and K.S. Bankiewicz Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease J. Neurosurg. 98 2003 136 144
45. R. Sanchez-Pernaute, A.L. Brownell, and O. Isacson Functional imaging of the dopamine system: in vivo evaluation of dopamine deficiency and restoration Neurotoxicology 23 2002 469 478
46. R. Sanchez-Pernaute, A. Ferree, O. Cooper, M. Yu, A.-L. Brownell, and O. Isacson Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease J. Neuroinflamm. 1 2004 6 14
47. H. Sauer, and W.H. Oertel Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401 415
48. C. Scali, M.G. Giovannini, C. Prosperi, A. Bellucci, G. Pepeu, and F. Casamenti The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo Neuroscience 117 2003 909 919
49. O. Ullrich, A. Diestel, I.Y. Eyupoglu, and R. Nitsch Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1 Nat. Cell Biol. 3 2001 1035 1042
50. U. Ungerstedt 6-Hydroxy-dopamine induced degeneration of central monoamine neurons Eur. J. Pharmacol. 5 1968 107 110
51. U. Ungerstedt, and G. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res. 24 1970 485 493
52. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, S. Gispert, Z. Ali, D. Del Turco, A.R. Bentivoglio, and D.G. Healy Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
53. Z. Zhang, A. Andersen, R. Grondin, T. Barber, R. Avison, G. Gerhardt, and D. Gash Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys Neuroimage 14 2001 1159 1167